Buscar en
Cirugía Española (English Edition)
Toda la web
Inicio Cirugía Española (English Edition) Major hepatectomies are safe in patients with cholangiocarcinoma and jaundice
Journal Information
Vol. 86. Issue 5.
Pages 296-302 (October 2009)
Share
Share
Download PDF
More article options
Vol. 86. Issue 5.
Pages 296-302 (October 2009)
Full text access
Major hepatectomies are safe in patients with cholangiocarcinoma and jaundice
Las hepatectomías mayores en pacientes con colangiocarcinoma e ictericia son seguras
Visits
1221
Joan Figuerasa,
Corresponding author
info@jfigueras.net

Corresponding author.
, Antoni Codina-Barrerasa, Santiago López-Bena, Jordi Sorianob, Berta Pardinac, Laia Falguerasa, Ernesto Castroa, Silvia Torres-Bahic, Rosa Ortizd, Esther Diazd, Albert Marotoe, Eugeni Canalsf
a Servicio de Cirugía, Hospital de Girona Dr Josep Trueta, Girona, Spain
b Institut de Diagnostic per la Imatge (IDI), Hospital de Girona Dr Josep Trueta, Girona, Spain
c Servicio de Anestesiología y Reanimación, Hospital de Girona Dr Josep Trueta, Girona, Spain
d Servicio de Anatomía Patológica, Hospital de Girona Dr Josep Trueta, Girona, Spain
e Servicio de Radiología, Hospital de Girona Dr Josep Trueta, Girona, Spain
f Servicio de Radioterapia, Institut Català d’Oncologia, Hospital de Girona Dr Josep Trueta, Girona, Spain
This item has received
Article information
Abstract
Background

Surgical resection is the only possibility of long term survival in patients with Klatskin tumours. However, surgical resection is a challenging problem and hepatic resection is often necessary.

Objective

The aim of our study was to assess the need for biliary drainage, resection rate and outcome of hilar cholangiocarcinoma in a single tertiary referral centre.

Patients and methods

From 2005 to 2008, 26 patients with Klatskin tumours were identified and assessed prospectively with multidetector CT and MR cholangiography in special cases. Seven patients (27%) were deemed to be unresectable in pre-operative staging. A total of 19 surgical procedures were performed, 8 left hepatectomies, 5 right hepatectomies, and 6 resections exclusively of the biliary tree.

Results

Resection rate was 73%, transfusion rate 53% and preoperative biliary drainage was performed only in 7 cases (37%). Major complications occurred in 11 (58%), including 2 postoperative deaths (10%).

There were no differences in the epidemiological data, when we separately analysed the outcomes of the 9 patients with bilirubin <15mg/dL and the 10 patients with bilirubin >15mg/dL. Biliary drainage was required in 6 (67%) patients in the group with low bilirubin levels versus 1 (10%) in the other group (P=.02). The mean bilirubin level in the jaundiced group was 22.1 (3.9) versus 4.7 (4.3) (P<.001) in the other group. There were no differences in the postoperative outcome between both groups.

Conclusion

Resection and survival rates have increased recently but still carries the risk of significant morbidity and mortality. Major hepatectomies in selected patients without percutaneous biliary drainage are safe.

Keywords:
Hilar cholangiocarcinoma
Klatskin tumor
Biliary drainage
Pathology
Treatment
Hepatectomy
Outcome
Resumen
Introducción

En el tumor de Klatskin la única posibilidad de cura es la extirpación quirúrgica radical. No obstante, la resección quirúrgica es difícil.

Objetivo

El objetivo de este trabajo es valorar la necesidad de drenaje biliar preoperatorio, el índice de resecabilidad, el porcentaje de hepatectomías, la morbimortalidad y la supervivencia a largo plazo.

Material y métodos

Desde el año 2005 hasta el año 2008, se estudió a 26 pacientes con tumor de Klatskin mediante tomografía computarizada helicoidal con multidetectores y colangiorresonancia magnética en casos especiales. Siete pacientes se consideraron irresecables (27%). A los restantes 19 pacientes se les realizaron 8 hepatectomías izquierdas, 5 derechas y 6 resecciones exclusivamente de la vía biliar con linfadenectomía y hepático yeyunostomía a todos ellos.

Resultados

La resecabilidad fue del 73%, la transfusión del 53% y el drenaje biliar preoperatorio se utilizó en 7 casos (37%). La morbilidad fue del 58% y la mortalidad del 10%. La supervivencia y la recidiva a los 48 meses fueron respectivamente del 63 y del 37%. Al comparar la evolución de los 9 pacientes con bilirrubina inferior a 15mg/dl y los 10 pacientes con bilirrubina superior a 15mg/dl, no hubo diferencias en los datos epidemiológicos. Seis pacientes (67%) con bilirrubina baja frente a un paciente (10%) del grupo de bilirrubina alta habían recibido un drenaje biliar preoperatorio (p=0,02). La bilirrubina del grupo no ictérico era de 4,7±4,3 frente a 22,1±3,9 del grupo con ictericia (p<0,001). No hubo diferencias en la evolución postoperatoria.

Conclusión

La resecabilidad y la supervivencia postoperatoria de los pacientes con tumor de Klatskin han mejorado sensiblemente en los últimos años. En casos seleccionados, las hepatectomías mayores en pacientes con ictericia sin desnutrición ni colangitis preoperatoria son seguras.

Palabras clave:
Colangiocarcinoma hiliar
Tumor de Klatskin
Drenaje biliar
Enfermedad
Tratamiento
Hepatectomía
Resultados
Full text is only aviable in PDF
References
[1.]
G. Klatskin.
Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis. An unusual tumour with distinctive clinical and pathological features.
Am J Med, 38 (1965), pp. 241-256
[2.]
L. Lladó, E. Ramos, J. Torras, J. Fabregat, R. Jorba, C. Valls, et al.
Resección radical del colangiocarcinoma hiliar. Indicaciones y resultados.
Cir Esp, 83 (2008), pp. 139-144
[3.]
E. Ramos Rubio.
Cirugía radical del colangiocarcinoma (tumor de Klatskin).
Cir Esp, 82 (2007), pp. 11-15
[4.]
F. Ito, R. Agni, R.J. Rettammel, M.J. Been, C.S. Cho, D.M. Mahvi, et al.
Resection of hilar cholangiocarcinoma: Concomitant liver resection decreases hepatic recurrence.
Ann Surg, 248 (2008), pp. 273-279
[5.]
Figueras, C. Valls, J. Fabregat, T. Serrano, E. Jaurrieta.
Equipamiento, experiencia mínima y estándares en la cirugía hepatobiliopancreática (HPB).
Cir Esp, 71 (2002), pp. 201-206
[6.]
T. Sano, K. Shimada, Y. Sakamoto, J. Yamamoto, S. Yamasaki, T. Kosuge, et al.
One hundred and two consecutive hepatobiliary resections for perihilar cholangiocarcinoma with zero mortality.
[7.]
A. Cherqui, et al.
Major liver resection for carcinoma in jaundiced patients without preoperative biliary drainage.
Arch Surg, 135 (2000), pp. 301
[8.]
J. Figueras, L. Llado, C. Valls, T. Serrano, E. Ramos, J. Fabregat, et al.
Changing strategies in diagnosis and management of hilar cholangiocarcinoma.
Liver Transpl, 6 (2000), pp. 786-794
[9.]
H. Bismuth, M.B. Corlette.
Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver.
Surg Gynecol Obstet, 140 (1975), pp. 170-178
[10.]
L.H. Sobin, C.H. Wittekind.
TNM classification of malignant tumors.
5th ed., Wiley and Sons Inc, (1997),
[11.]
J.I. Tsao, Y. Nimura, Kamiya, N. Hayakawa, S. Kondo, M. Nagino, et al.
Management of hilar cholangiocarcinoma. Comparison of an American and Japanese experience.
Ann. Surg., 232 (2000), pp. 166-174
[12.]
C.L. Liu, S.T. Fan, C.M. Lo, W.K. Tso, C.M. Lam, J. Wong.
Improved operative and survival outcomes of surgical treatment for hilar cholangiocarcinoma.
Br J Surg, 93 (2006), pp. 1488-1494
[13.]
S.D. Mansfield, O. Barakat, R.M. Charnley, B.C. Jaques, C.B. O'Suilleabhain, P.J. Atherton, et al.
Management of hilar cholangiocarcinoma in the North of England: Pathology, treatment, and outcome.
World J Gastroenterol, 11 (2005), pp. 7625-7630
[14.]
A.W. Hemming, A.I. Reed, S. Fujita, D.P. Foley, R.J. Howard.
Surgical management of hilar cholangiocarcinoma.
Ann Surg, 241 (2005), pp. 693-702
[15.]
S.G. Lee, Y.J. Lee, K.M. Park, S. Hwang, P.C. Min.
One hundred and eleven liver resections for hilar bile duct cancer.
J Hepatobiliary Pancreat Surg, 7 (2000), pp. 135-141
[16.]
T. Noie, Y. Sugawara, H. Imamura, T. Takayama, M. Makuuchi.
Selective versus total drainage for biliary obstruction in the hepatic hilus: An experimental study.
Surgery, 130 (2001), pp. 74-81
[17.]
G.D. de Palma, G. Galloro, S. Siciliano, P. Iovino, C. Catanzano.
Unilateral versus bilateral endoscopic hepatic duct drainage in patients with malignant hilar biliary obstruction: Results of a prospective, randomized, and controlled study.
Gastrointest Endosc, 53 (2001), pp. 547-553
[18.]
R. Rerknimitr, N. Kladcharoen, V. Mahachai, P. Kullavanijaya.
Result of endoscopic biliary drainage in hilar cholangiocarcinoma.
J Clin Gastroenterol, 38 (2004), pp. 518-523
[19.]
G. Sugawara, M. Nagino, H. Nishio, T. Ebata, K. Takagi, T. Asahara, et al.
Peroperative symbiotic treatment to prevent postoperative infectious complications in biliary cancer surgery.
[20.]
T. Kosuge, J. Yamamoto, K. Shimada, S. Yamasaki, M. Makuuchi.
Improved surgical results of hilar cholangiocarcinoma with procedures including major hepatic resection.
Ann Surg, 230 (1999), pp. 663-671
[21.]
B. Launois, J. Terblanche, M. Lakehal, J.M. Catheline, E. Bordaxoglou, S. Landen, et al.
Proximal bile duct cancer: High respectability rate and 5-year survival.
Ann Surg, 230 (1999), pp. 266-275
[22.]
W.R. Jarnagin, Y. Fong, R.P. DeMatteo, M. Gonen, E.C. Burke, B.S.J. Bodniewicz, et al.
Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma.
Ann Surg, 234 (2001), pp. 507-517
[23.]
J. Klempnauer, G.J. Ridder, R. von Wasielewski, M. Werner, A. Weimann, R. Pilchmayr.
Resectional surgery of hilar cholangiocarcinoma: A multivariate analysis of prognostic factors.
J Clin Oncol, 15 (1997), pp. 947-954
[24.]
P. Neuhaus, S. Jonas, U. Settmacher, et al.
Surgical management of proximal bile duct cancer: Extended right lobe resection increases resectability and radicality.
Langenbecks Arch Surg, 388 (2003), pp. 194-200
Copyright © 2009. Asociación Española de Cirujanos
Article options
Tools
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos